Mrs Ellen Gielen > CMS > Amsterdam, Netherlands > Lawyer Profile

CMS
ATRIUM
PARNASSUSWEG 737
1077 DG AMSTERDAM
Netherlands

Work Department

Life Sciences & Healthcare

Position

Partner

Career

Ellen leads the regulatory practice and is an expert in regulatory, compliance and complex contractual matters and represents leading life science companies, like Amgen, Boston Scientific and Johnson & Johnson, on a range of pharmaceutical and medical device product issues, including manufacturing & distribution, pricing & reimbursement and advertising, both on domestic and EU level.

In this respect, she is renowned for developing and securing innovative partnership models in the field of “patient support programs” and “hospital solutions”. Ellen is also an experienced litigator related to life sciences matters.

Languages

English, Dutch

Memberships

  • Dutch Pharmaceutical Law Association
  • Complaints Committee of a BOPZ Institution, an institution governed by the Psychiatric Hospitals Compulsory Admission Act
  • Dutch Standardisation Institute (NEN) on MDR and IVDR topics (panel member)

Education

  • Dutch Law (Company Law), Erasmus University
  • Business Administration, Erasmus University

Lawyer Rankings

Netherlands > Industry focus: healthcare and life sciences

(Leading individuals)

Ellen GielenCMS

The team at CMS exhibits broad expertise across a diverse range of matters, including the restructuring of licenses, joint projects between pharma companies and healthcare institutions, and pricing and reimbursement negotiations. Practice head Ellen Gielen is known for her vast regulatory expertise, particularly in relation to pricing and reimbursement as well as manufacturing and distribution mandates. Judith Kok maintains a regulatory-focused practice, advising on the handling and marketing of medical devices and biocides, while Gertie Lintjens primarily advises clients in the pharma and medical device industries on early access issues and R&D projects, in addition to advertising and transparency disputes.